Temozolomide salvage chemotherapy for recurrent anaplastic oligodendroglioma and oligo-astrocytoma.

J Korean Neurosurg Soc · 2013 · PMC3921276 · PMID 24527191

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

In our study, chemo-naive patients showed apparently higher response rate (8 of 29 patients, 28%) than chemo-experienced patients (9 of 43 patients, 21%), but the difference failed to reach statistical significance.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.